USE OF TLR8 AGONISTS TO TREAT CANCER

• 收藏
• 分享

专利权人:

VentiRx Pharmaceuticals; Inc.

发明人:

Gregory N. DIETSCH

申请号：

US15771662

公开号：

US20180303845A1

申请日:

2016.11.02

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The application relates to methods of inducing antitumor immune responses in a subject having cancer. In some embodiments, methods are provided for administering to a subject in need thereof a TLR8 agonist and a PD1-1/PD-L1 antagonist, optionally including one or more additional therapeutic agents.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/